Trial Profile
A retrospective pilot study of bivalirudin versus unfractionated heparin as an adjunct to transcatheter aortic valve interventions.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Nov 2011
Price :
$35
*
At a glance
- Drugs Bivalirudin (Primary) ; Heparin
- Indications Thrombosis
- Focus Adverse reactions
- Acronyms BRAVO
- 14 Nov 2011 New trial record
- 08 Nov 2011 Results were presented at the 2011 Transcatheter Cardiovascular Therapeutics conference, according to a media release from The Medicines Company. Results were also reported in the media release.